Actively Recruiting
Assessment of Metabolic Complications in Patients With Adrenal Tumors Through Radiological Images
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-30
1000
Participants Needed
1
Research Sites
8 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research focuses on patients with adrenal tumors and aims to study metabolic complications using existing radiological images. It is a retrospective observational study that collects data already available at participating centers. The purpose is to analyze CT images through radiomics to help differentiate between benign and malignant adrenal masses, and to explore associations with biological markers and disease progression. Patients included in the study have adrenal tumors and have undergone abdominal CT scans whose images are stored in DICOM format. These images, along with clinical and histological data when available, will be pseudonymized and securely transferred to a central center for radiomics analysis. This process will not affect the patients' medical care as it uses past data only. Participants' involvement consists of use of their previously collected CT images and medical information. The research team will measure diagnostic accuracy of radiomics parameters for tumor classification and examine their relation to Ki67 values, Weiss' score, and occurrence of distant metastasis. Data security is ensured by restricting image access to authorized personnel only. The study is expected to complete within about one year from start date in 2025.
CONDITIONS
Brief Title
Assessment of Metabolic Complications in Patients With Adrenal Tumors Through Radiological Images
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Patients with adrenal tumor who underwent adrenectomy surgery from 1-1-2000 to 30-5-2023 with available histologic diagnosis
- Patients with adrenal tumor that did not undergo adrenectomy surgery with diagnosis of benignity confirmed by radiologic stability at 6-12 months after first finding
- Availability of radiological images in DICOM format of abdominal CT scan at first evaluation before surgery
- Signature of informed consent
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 year
Participants' existing abdominal CT scan images are collected and analyzed to assess metabolic complications related to adrenal tumors.
No additional visits; analysis is performed on existing imaging data
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy, 40138
Actively Recruiting
Research Team
G
Guido Di Dalmazi, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here